Adult Incontinence Products Market: By Product Type (Protective Garments [Disposable Adult Diaper, Disposable Under Pads, Disposable Pull Up Pants, Others], Urine Bag [Leg Urine Bag, Bedside Urine Bag], Urinary Catheter [Indwelling (Foley) Catheter, Intermittent Catheter, External Catheter]), By Usage(Reusable, Disposable), By Distribution channel (Institutional sales, retail sales, online channel), By Application (Chronic Kidney Failure, Benign Prostatic Hyperplasia, Bladder Cancer, Kidney Stone, Others), and Geography

Adult Incontinence Products Market was valued at USD 13,328.6 million in 2023, growing at a 7.7% CAGR from 2024 to 2030. Urinary incontinence refers to the involuntary leakage of urine. Similarly, fecal incontinence refers to the involuntary leakage of stool due to the inability to control bowel movements. According to the United Nations Organisation, the aging population of the world is estimated to reach 1.4 billion by 2030, representing a huge incontinence care products market growth opportunity. Incontinence is more common in females as compared to males.

The demand for incontinence devices is increasing rapidly, with the rising prevalence of incontinence and active government support. The key factors propelling the growth of the market studied are the rising prevalence of renal diseases and nephrological injuries, technological advancements in the material used for disposable products and catheters, and increasing awareness about personalized care and hygiene. For instance, according to a research study in 2021, the prevalence of UI ranged from 20.3% to 54.5%. Stress UI was the main type reported. The main predisposing factors were chronic respiratory diseases and constipation. Thus, the rising prevalence of diseases is expected to boost the market during the forecast period. New product launches are expected to fuel the market during the forecast period. Thus, the market strategies opted by suppliers and manufacturers will contribute toward the growth of the market. However, the severity of side effects associated with the continuous use of incontinence products and limited reimbursement are expected to restrain the growth of the market during the forecast period

Adult Incontinence Products Market Key Developments:

• In December 2021, Otsuka Pharmaceutical Factory Inc. launched an intermittent urological catheter, "Actreen," a medical device, for which OPF concluded an exclusive marketing agreement with B. Braun Aesculap Japan Co. Ltd. This product is a single-use catheter consisting of a catheter (tube) and connector that can be used during self-catheterization in people who have lost the urge to urinate or who usually have difficulty urinating. 
• In March 2022, the US-based Sonoma Pharmaceuticals, a global healthcare leader, launched Microdox, a urinary tract infection catheter and bladder rinse in New Zealand, Australia, and South Africa. 
• In November 2021, the Flume Catheter Company Ltd (TFCC), a medical device company dedicated to developing an improved alternative to the Foley indwelling urinary catheter, announced that it received clearance from the US Food and Drug Administration (FDA) to market the Flume catheter in the United States.